Clinical digest. Trial proves apremilast is effective long-term treatment for psoriasis

October 2012
Nursing Standard;10/10/2012, Vol. 27 Issue 6, p14
Trade Publication
The article discusses research in the article "Efficacy of Apremilast in the Treatment of Moderate to Severe Psoriasis: A Randomised Controlled Trial" by K. Papp et al. which found that the drug apremilast is effective for the long term treatment of psoriasis.


Related Articles

  • Patients with psoriasis may be helped by counseling.  // Modern Medicine;Sep96, Vol. 64 Issue 9, p58 

    Presents an abstract of the research report entitled `Effects of Psychologic Intervention on Psoriasis: A Preliminary Report,' by R. Zachariae, et al published in the June 1996 issue of the `Journal of American Academy of Dermatology.'

  • Could mycophenolate mofetil play a role in treatment of recalcitrant psoriasis? Newman, Laura // Dermatology Times;Nov96 Supplement Psoriasis, Vol. 17 Issue 11, pS6 

    Examines the efficacy of mycophenolate mofetil (MMF) in the treatment of psoriasis. Characteristics; Possibility of immunosuppressive side effects; Comparison of bioavailability with mycophenolic acid; Cost of treatment.

  • New therapeutic modalities offer psoriasis patients hope for their condition. Zabel, Karen // Dermatology Times;Nov96 Supplement Psoriasis, Vol. 17 Issue 11, pS9 

    Examines therapeutic modalities for psoriasis patients. Absorption rate of Neoral, a predigested form of cyclosporine manufactured by Sandoz; Unpredictable absorption rate of Sandimmune; Efficacy comparison of Neoral and Sandimmune; Micanol; Tazarotene manufactured by Allergan; Acitretin...

  • Treatment of soles, palms for psoriasis may be tricky. Zabel, Karen // Dermatology Times;Nov96 Supplement Psoriasis, Vol. 17 Issue 11, pS21 

    Addresses the difficulty of treating psoriasis located on the palms and soles of feet. Reason for difficulty of treatment; Topical medication as first line of treatment; Advantages and disadvantages of steroid use; Benefits of using oral psoralen combined with UVA phototherapy (PUVA); Efficacy...

  • Psoriasis therapies: Old, new, and borrowed. Burrall, Barbara A.; Dijkstra, Jacob W.E. // Patient Care;10/30/1995, Vol. 29 Issue 17, p38 

    Provides information on various treatment modalities for psoriasis. Clinical features of the disease; Differentiating from other skin diseases; Less common forms of psoriasis; Treating mild, chronic, stable psoriasis; Using topical corticosteroids; Using calsipotriene as alternative to...

  • New help for psoriasis.  // Redbook;Nov94, Vol. 184 Issue 1, p22 

    Reports on the approval of the prescription ointment, Dovonex, as a treatment for psoriasis by the Food and Drug Administration (FDA). Component; Result of product tests; Side effects.

  • Trial drug may be safe oral treatment for psoriasis. Guttman, Cheryl // Dermatology Times;Mar1995, Vol. 16 Issue 3, p40 

    Reports that glucosaminyl muramyl dipeptide (GMDP) may be a safe and effective oral treatment for psoriasis. Dosage; Toleration level; Side effect; Manufacturer of GMDP.

  • Rotational therapy in psoriasis helps lower toxicity risk. Newman, Laura // Dermatology Times;Mar1995, Vol. 16 Issue 3, p65 

    Reports that rotation of different therapies for psoriasis is needed to minimize the risk of long-term toxicities. Guidelines; Dimensions of safe rotational therapy; Example of potentially damaging long-term use of a single agent therapy.

  • Psoriasis treatable with medication, light therapy.  // Dermatology Times;Jul95, Vol. 16 Issue 7, p49 

    Presents an abstract of an article on the treatment of psoriasis published in `FDA Consumer' magazine dated April 1995.

  • Psoriasis tx offers long-term remission.  // Dermatology Times;Sep96, Vol. 17 Issue 9, p65 

    Features a drug that offers long-term remission for psoriasis patients by penetrating and treating skin cells where they develop.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics